日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study

Xaluritamig,一种针对转移性去势抵抗性前列腺癌的STEAP1 × CD3 XmAb 2+1免疫疗法:首次人体试验剂量探索结果

Kelly, William K; Danila, Daniel C; Lin, Chia-Chi; Lee, Jae-Lyun; Matsubara, Nobuaki; Ward, Patrick J; Armstrong, Andrew J; Pook, David; Kim, Miso; Dorff, Tanya B; Fischer, Stefanie; Lin, Yung-Chang; Horvath, Lisa G; Sumey, Christopher; Yang, Zhao; Jurida, Gabor; Smith, Kristen M; Connarn, Jamie N; Penny, Hweixian L; Stieglmaier, Julia; Appleman, Leonard J

PSMA-positive Circulating Tumor Cell Detection and Outcomes with Abiraterone or Enzalutamide Treatment in Men with Metastatic Castrate-resistant Prostate Cancer

PSMA阳性循环肿瘤细胞检测及转移性去势抵抗性前列腺癌患者接受阿比特龙或恩扎卢胺治疗的预后

Gupta, Santosh; Halabi, Susan; Yang, Qian; Roy, Akash; Tubbs, Alisa; Gore, Yamini; George, Daniel J; Nanus, David M; Antonarakis, Emmanuel S; Danila, Daniel C; Szmulewitz, Russell Z; Wenstrup, Richard; Armstrong, Andrew J

Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer Patients

快速基因检测模式对晚期前列腺癌患者的临床影响

Breen, Kelsey E; Symecko, Heather; Spielman, Kelsey; Gebert, Rebecca; Shah, Ibrahim H; Pundock, Stacy; Batson, Melissa; Narayan, Vivek K; Stadler, Zsofia K; Autio, Karen A; Abida, Wassim; Danila, Daniel C; Scher, Howard I; Morris, Michael J; Hamilton, Jada G; Robson, Mark E; Domchek, Susan M; Carlo, Maria I

Cancer Associated Macrophage-like Cells Are Prognostic for Highly Aggressive Prostate Cancer in Both the Non-Metastatic and Metastatic Settings

癌症相关巨噬细胞样细胞在非转移性和转移性前列腺癌中均具有预后价值。

Gironda, Daniel J; Bergan, Raymond C; Alpaugh, R Katherine; Danila, Daniel C; Chuang, Tuan L; Hurtado, Brenda Y; Ho, Thai; Adams, Daniel L

Evaluating Immune-Related Adverse Events Using PRO-CTCAE in a Phase II Study of Ipilimumab for Hormone-Sensitive Prostate Cancer

在伊匹木单抗治疗激素敏感性前列腺癌的II期研究中,使用PRO-CTCAE评估免疫相关不良事件

de Almeida, Daniel Vargas P; Anderson, Justine M; Danila, Daniel C; Morris, Michael J; Slovin, Susan F; Abida, Wassim; Cohn, Erica D; Baser, Raymond E; Scher, Howard I; Autio, Karen A

Health-related quality of life in GALAHAD: A multicenter, open-label, phase 2 study of niraparib for patients with metastatic castration-resistant prostate cancer and DNA-repair gene defects

GALAHAD研究中与健康相关的生活质量:一项针对转移性去势抵抗性前列腺癌伴DNA修复基因缺陷患者的尼拉帕尼多中心、开放标签II期研究

Smith, Matthew R; Sandhu, Shahneen; George, Daniel J; Chi, Kim Nguyen; Saad, Fred; Thiery-Vuillemin, Antoine; Stàhl, Olaf; Olmos, David; Danila, Daniel C; Gafanov, Rustem; Castro, Elena; Moon, Helen; Joshua, Anthony M; Mason, Gary E; Espina, Byron M; Liu, Yan; Lopez-Gitlitz, Angela; Francis, Peter; Bevans, Katherine B; Fizazi, Karim

Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer

前列腺癌肿瘤组织测序后的基因型确诊性种系检测

Truong, Hong; Breen, Kelsey; Nandakumar, Subhiksha; Sjoberg, Daniel D; Kemel, Yelena; Mehta, Nikita; Lenis, Andrew T; Reisz, Peter A; Carruthers, Jessica; Benfante, Nicole; Joseph, Vijai; Khurram, Aliya; Gopalan, Anuradha; Fine, Samson W; Reuter, Victor E; Vickers, Andrew J; Birsoy, Ozge; Liu, Ying; Walsh, Michael; Latham, Alicia; Mandelker, Diana; Stadler, Zsofia K; Pietzak, Eugene; Ehdaie, Behfar; Touijer, Karim A; Laudone, Vincent P; Slovin, Susan F; Autio, Karen A; Danila, Daniel C; Rathkopf, Dana E; Eastham, James A; Chen, Yu; Morris, Michael J; Offit, Kenneth; Solit, David B; Scher, Howard I; Abida, Wassim; Robson, Mark E; Carlo, Maria I

Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial

尼拉帕尼治疗伴有DNA修复基因缺陷的转移性去势抵抗性前列腺癌患者(GALAHAD):一项多中心、开放标签的II期试验

Smith, Matthew R; Scher, Howard I; Sandhu, Shahneen; Efstathiou, Eleni; Lara, Primo N Jr; Yu, Evan Y; George, Daniel J; Chi, Kim N; Saad, Fred; Ståhl, Olof; Olmos, David; Danila, Daniel C; Mason, Gary E; Espina, Byron M; Zhao, Xin; Urtishak, Karen A; Francis, Peter; Lopez-Gitlitz, Angela; Fizazi, Karim

Differences in Prostate Cancer Genomes by Self-reported Race: Contributions of Genetic Ancestry, Modifiable Cancer Risk Factors, and Clinical Factors

按自我报告种族划分的前列腺癌基因组差异:遗传祖先、可改变的癌症风险因素和临床因素的影响

Stopsack, Konrad H; Nandakumar, Subhiksha; Arora, Kanika; Nguyen, Bastien; Vasselman, Samantha E; Nweji, Barbara; McBride, Sean M; Morris, Michael J; Rathkopf, Dana E; Slovin, Susan F; Danila, Daniel C; Autio, Karen A; Scher, Howard I; Mucci, Lorelei A; Solit, David B; Gönen, Mithat; Chen, Yu; Berger, Michael F; Schultz, Nikolaus; Abida, Wassim; Kantoff, Philip W

Automated Bone Scan Index to Optimize Prostate Cancer Working Group Radiographic Progression Criteria for Men With Metastatic Castration-Resistant Prostate Cancer

自动骨扫描指数优化前列腺癌工作组转移性去势抵抗性前列腺癌患者的放射学进展标准

Anand, Aseem; Heller, Glenn; Fox, Joseph; Danila, Daniel C; Bjartell, Anders; Edenbrandt, Lars; Larson, Steven M; Scher, Howard I; Morris, Michael J